Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP operating income by Quarter
Non-GAAP operating income ($M) ($M)
Vertex Pharmaceuticals Non-GAAP operating income: $1,423M in Q2 2026, up 7.4% from a year earlier. That is the highest of the 26 quarters on record here.
Where the Q2 2026 figure comes from
“|| Non-GAAP operating income | $ | 1,423.3 | $ | 1,325.1 | $ | 2,733.6 | $ | 2,508.1”
Source: Form 8-K (ex-991_q22026.htm, filed 2026-08-03) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP operating income ($M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-opinc
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.